Pfizer has kicked off a late-stage trial assessing efficacy and safety of the investigational gene therapy fidanacogene elaparvovec for the treatment of haemophilia B. The Phase III lead-in study has been initiated following completion of […]
MPs have voted 305-301 that the UK should negotiate to remain part of the European Medicines Agency following Brexit. “Parliament has sent a clear message that patients and public health should be a top priority […]
The National Institute for Health and Care Excellence has released new draft guidelines calling for faster treatment of patients with kidney stones experiencing severe pain. The Institute is backing wider access to a procedure called […]
Indian pharmaceutical company Cipla has signed an agreement to fully acquire South Africa-based pharmaceutical manufacturer Mirren for R450m ($33.5m). Cipla entered the deal through its wholly owned South African subsidiary Cipla Medpro, which produces medicines […]
US-based biotechnology company Pliant Therapeutics has secured new funding in a series B financing round to support and advance its therapeutic programmes for fibrotic diseases. The $62m funding round was led by Cowen Healthcare Investments. […]